Amy Welsh
Corporate Officer/Principal presso AGILE THERAPEUTICS, INC.
Patrimonio netto: 4 590 $ in data 31/03/2024
Profilo
Amy Welsh is currently the Chief Commercial Officer at Agile Therapeutics, Inc. She previously worked as the Vice President-Marketing at Antares Pharma, Inc. from 2017 to 2020.
Ms. Welsh completed her undergraduate degree at LaSalle University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
AGILE THERAPEUTICS, INC.
0.20% | 28/06/2023 | 13 500 ( 0.20% ) | 4 590 $ | 31/03/2024 |
Posizioni attive di Amy Welsh
| Società | Posizione | Inizio |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Precedenti posizioni note di Amy Welsh
| Società | Posizione | Fine |
|---|---|---|
| ANTARES PHARMA, INC. | Sales & Marketing | 01/05/2020 |
Formazione di Amy Welsh
| LaSalle University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Borsa valori
- Insiders
- Amy Welsh
